Philip Ross

Philip Ross is an accomplished professional in the field of analytical development and quality control, currently serving as Senior Director at Wave Life Sciences since November 2017, where responsibilities include building and growing the Analytical/QC department to support a novel chemistry platform at a GMP manufacturing facility. Previously, Philip held various leadership roles in analytical development at Nitto Denko Avecia Inc. and Pace® Analytical Services, overseeing teams in cGMP environments and supporting IND-enabling projects. Philip's extensive background also includes significant contributions at AstraZeneca, Sciex, Applied Biosystems, and Walter Reed Army Medical Center, focusing on mass spectrometry, drug development, and novel analytical methodologies. Philip holds a PhD in Analytical Chemistry from the University of Delaware and a RAC certification in Regulatory Affairs and Health Policy.